THE ROLE OF HEPATITIS-C VIRUS IN FULMINANT VIRAL-HEPATITIS IN AN AREA WITH ENDEMIC HEPATITIS-A AND HEPATITIS-B

被引:92
作者
CHU, CM [1 ]
SHEEN, IS [1 ]
LIAW, YF [1 ]
机构
[1] CHANG GUNG MED COLL, TAIPEI, TAIWAN
关键词
D O I
10.1016/0016-5085(94)90076-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: The role of hepatitis C virus in fulminant hepatitis remains controversial and needs further investigation. The aim of this study was to examine the role of hepatitis C virus in fulminant hepatitis in an area with endemic hepatitis A and B. Methods: Serological markers of hepatitis C virus were studied in 62 adults from Taiwan with fulminant viral hepatitis. Results: Of 62 patients, 5 (8.1%) were infected with acute type B hepatitis, 11 (17.7%) were infected with acute non-A, non-B hepatitis, and the remaining 46 (74.2%) were hepatitis B surface antigen (HBsAg) positive but immunoglobulin M (IgM) antibody to hepatitis B core antigen negative. Of the latter, 11 (23.9%) were IgM antibody to hepatitis D virus positive, 16 (34.8%) had high-titered serum hepatitis B virus DNA (>1000 pg/mL) and were suspected to have hepatitis B virus reactivation, and the other 19 (41.3%) had no identified causes. Serum hepatitis C virus RNA was found in 5 (45.5%) of 11 patients with fulminant non-A, non-B hepatitis, 3 (27.3%) of 11 HBsAg carriers with delta superinfection, and 6 (31.6%) of 19 HBsAg carriers with fulminant hepatitis of undetermined cause. Conclusions: Nearly half of fulminant non-A, non-B hepatitis and about 20% of HBsAg carriers with superimposed fulminant hepatitis in Taiwan could be attributed to hepatitis C virus infection. © 1994.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 45 条
  • [1] ARANKALLE VA, 1988, LANCET, V1, P550
  • [2] VIROLOGICAL MARKERS AND ANTIBODY-RESPONSES IN FULMINANT VIRAL-HEPATITIS
    BAL, V
    AMIN, SN
    RATH, S
    KAMAT, SA
    ZUCKERMAN, AJ
    MARATHE, SN
    KAMAT, RS
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1987, 23 (01) : 75 - 82
  • [3] FULMINANT AND SUBFULMINANT LIVER-FAILURE - DEFINITIONS AND CAUSES
    BERNUAU, J
    RUEFF, B
    BENHAMOU, JP
    [J]. SEMINARS IN LIVER DISEASE, 1986, 6 (02) : 97 - 106
  • [4] WILD-TYPE AND E-ANTIGEN-MINUS HEPATITIS-B VIRUSES AND COURSE OF CHRONIC HEPATITIS
    BRUNETTO, MR
    GIARIN, MM
    OLIVERI, F
    CHIABERGE, E
    BALDI, M
    ALFARANO, A
    SERRA, A
    SARACCO, G
    VERME, G
    WILL, H
    BONINO, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) : 4186 - 4190
  • [5] CARMAN WF, 1989, LANCET, V2, P588
  • [6] ASSOCIATION OF A PRECORE GENOMIC VARIANT OF HEPATITIS-B VIRUS WITH FULMINANT-HEPATITIS
    CARMAN, WF
    FAGAN, EA
    HADZIYANNIS, S
    KARAYIANNIS, P
    TASSOPOULOS, NC
    WILLIAMS, R
    THOMAS, HC
    [J]. HEPATOLOGY, 1991, 14 (02) : 219 - 222
  • [7] CHEN CY, 1993, CHIN J GASTROENTEROL, V10, P90
  • [8] ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME
    CHOO, QL
    KUO, G
    WEINER, AJ
    OVERBY, LR
    BRADLEY, DW
    HOUGHTON, M
    [J]. SCIENCE, 1989, 244 (4902) : 359 - 362
  • [9] THE ETIOLOGY OF ACUTE HEPATITIS IN TAIWAN - ACUTE HEPATITIS SUPERIMPOSED ON HBSAG CARRIER STATE AS THE MAIN ETIOLOGY OF ACUTE HEPATITIS IN AREAS WITH HIGH HBSAG CARRIER RATE
    CHU, CM
    SHEEN, IS
    LIAW, YF
    [J]. INFECTION, 1988, 16 (04) : 233 - 237
  • [10] THE ETIOLOGY OF ACUTE HEPATITIS SUPERIMPOSED UPON PREVIOUSLY UNRECOGNIZED ASYMPTOMATIC HBSAG-CARRIERS
    CHU, CM
    LIAW, YF
    PAO, CC
    HUANG, MJ
    [J]. HEPATOLOGY, 1989, 9 (03) : 452 - 456